Skip to main navigation Skip to search Skip to main content

Prognostic value of cytokine concentrations (tumor necrosis factor-α, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis

  • Andrew J.H. Simpson
  • , Michael D. Smith
  • , Gerrit Jan Weverling
  • , Yupin Suputtamongkol
  • , Brian J. Angus
  • , Wipada Chaowagul
  • , Nicholas J. White
  • , Sander J.H. Van Deventer
  • , Jan M. Prins
  • Faculty of Tropical Medicine, Mahidol University
  • Nuffield Department of Medicine
  • Taunton and Somerset Hospital
  • University of Amsterdam
  • Sapasittiprasong Hospital

Research output: Contribution to journalArticlepeer-review

95 Citations (Scopus)

Abstract

Raised serum concentrations of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, or IL-10 are associated with mortality in patients with sepsis, but it is not known whether elevated cytokine levels are independently predictive of mortality. Cytokine assays (TNF-α, IL-6, and IL-10) were performed on admission plasma samples from 172 adult Thai patients with severe melioidosis. Mortality was 31.4%. APACHE II score; septicemia; plasma lactate; TNF-α, IL-6, and IL-10 concentrations; and IL- 10/TNF-α and IL-6/IL-10 ratios were each associated with outcome (P ≤ .001 for all variables). Only the APACHE II score and either IL-6 or IL-10 concentration were independent predictors of mortality, as determined by use of multiple logistic regression (with cytokine concentrations and ratios entered separately). In a multivariate analysis, including both IL-6 and IL- 10, the IL-10 concentration was no longer predictive. Therefore, APACHE II scores and either IL-6 or IL-10 concentration may be the most reliable parameters for stratification of patients in future studies of severe gram- negative sepsis.

Original languageEnglish
Pages (from-to)621-625
Number of pages5
JournalJournal of Infectious Diseases
Volume181
Issue number2
DOIs
Publication statusPublished - 2000

Fingerprint

Dive into the research topics of 'Prognostic value of cytokine concentrations (tumor necrosis factor-α, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis'. Together they form a unique fingerprint.

Cite this